288 related articles for article (PubMed ID: 2988685)
1. The use of [3H]-[D-Pen2,D-Pen5]enkephalin as a highly selective ligand for the delta-binding site.
Cotton R; Kosterlitz HW; Paterson SJ; Rance MJ; Traynor JR
Br J Pharmacol; 1985 Apr; 84(4):927-32. PubMed ID: 2988685
[TBL] [Abstract][Full Text] [Related]
2. Characterization of [3H][2-D-penicillamine, 5-D-penicillamine]-enkephalin binding to delta opiate receptors in the rat brain and neuroblastoma--glioma hybrid cell line (NG 108-15).
Akiyama K; Gee KW; Mosberg HI; Hruby VJ; Yamamura HI
Proc Natl Acad Sci U S A; 1985 Apr; 82(8):2543-7. PubMed ID: 2986120
[TBL] [Abstract][Full Text] [Related]
3. Opioid binding sites in the guinea pig and rat kidney: radioligand homogenate binding and autoradiography.
Dissanayake VU; Hughes J; Hunter JC
Mol Pharmacol; 1991 Jul; 40(1):93-100. PubMed ID: 1649966
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of mu and delta but not kappa opioid binding to membranes by Fab fragments from a monoclonal antibody directed against the opioid receptor.
Bidlack JM; O'Malley WE
J Biol Chem; 1986 Dec; 261(34):15844-9. PubMed ID: 3023329
[TBL] [Abstract][Full Text] [Related]
5. Binding of [3H][D-Ala2, MePhe4, Gly-ol5] enkephalin, [3H][D-Pen2, D-Pen5]enkephalin, and [3H]U-69,593 to airway and pulmonary tissues of normal and sensitized rats.
Bhargava HN; Villar VM; Cortijo J; Morcillo EJ
Peptides; 1997; 18(10):1603-8. PubMed ID: 9437722
[TBL] [Abstract][Full Text] [Related]
6. Binding characteristics of [D-Ala2-MePhe4-Glyol5] enkephalin and [D-Pen2,D-Pen5] enkephalin in rat brain: inhibition studies with fentanyl-like drugs.
Yeadon M; Kitchen I
NIDA Res Monogr; 1986; 75():64-6. PubMed ID: 2829008
[TBL] [Abstract][Full Text] [Related]
7. Quantitative analysis of multiple kappa-opioid receptors by selective and nonselective ligand binding in guinea pig spinal cord: resolution of high and low affinity states of the kappa 2 receptors by a computerized model-fitting technique.
Tiberi M; Magnan J
Mol Pharmacol; 1990 May; 37(5):694-703. PubMed ID: 2160061
[TBL] [Abstract][Full Text] [Related]
8. Opioid receptor ligands in the neonatal rat spinal cord: binding and in vitro depression of the nociceptive responses.
James IF; Bettaney J; Perkins MN; Ketchum SB; Dray A
Br J Pharmacol; 1990 Mar; 99(3):503-8. PubMed ID: 2158845
[TBL] [Abstract][Full Text] [Related]
9. Role of steric interactions in the delta opioid receptor selectivity of [D-Pen2, D-Pen5]enkephalin.
Mosberg HI; Haaseth RC; Ramalingam K; Mansour A; Akil H; Woodard RW
Int J Pept Protein Res; 1988 Jul; 32(1):1-8. PubMed ID: 2851561
[TBL] [Abstract][Full Text] [Related]
10. Selectivity of ligand binding to opioid receptors in brain membranes from the rat, monkey and guinea pig.
Clark MJ; Carter BD; Medzihradsky F
Eur J Pharmacol; 1988 Apr; 148(3):343-51. PubMed ID: 2898375
[TBL] [Abstract][Full Text] [Related]
11. Opiate binding in calf thalamic membranes: a selective mu 1 binding assay.
Clark JA; Houghten R; Pasternak GW
Mol Pharmacol; 1988 Sep; 34(3):308-17. PubMed ID: 2901663
[TBL] [Abstract][Full Text] [Related]
12. Effects of intracerebroventricular beta-funaltrexamine on mu and delta opioid receptors in the rat: dichotomy between binding and antinociception.
Liu-Chen LY; Li SX; Wheeler-Aceto H; Cowan A
Eur J Pharmacol; 1991 Oct; 203(2):195-202. PubMed ID: 1666046
[TBL] [Abstract][Full Text] [Related]
13. Identification and characterization of delta opioid binding sites in the bovine pineal.
Aloyo VJ
J Pharmacol Exp Ther; 1992 Jul; 262(1):292-7. PubMed ID: 1320688
[TBL] [Abstract][Full Text] [Related]
14. Effects of NMDA receptor antagonists on delta1- and delta2-opioid receptor agonists-induced changes in the mouse brain [3H]DPDPE binding.
Cao YJ; Bian JT; Bhargava HN
Eur J Pharmacol; 1997 Sep; 335(2-3):161-6. PubMed ID: 9369369
[TBL] [Abstract][Full Text] [Related]
15. [3H][D-Ser2(O-tert-butyl),Leu5]enkephalyl-Thr6 and [D-Ser2(O-tert-butyl),Leu5]enkephalyl-Thr6(O-tert-butyl). Two new enkephalin analogs with both a good selectivity and a high affinity toward delta-opioid binding sites.
Delay-Goyet P; Seguin C; Gacel G; Roques BP
J Biol Chem; 1988 Mar; 263(9):4124-30. PubMed ID: 2831220
[TBL] [Abstract][Full Text] [Related]
16. Probing the opioid receptor complex with (+)-trans-superfit. I. Evidence that [D-Pen2,D-Pen5]enkephalin interacts with high affinity at the delta cx binding site.
Rothman RB; Mahboubi A; Bykov V; Kim CH; Jacobson AE; Rice KC
Peptides; 1991; 12(2):359-64. PubMed ID: 1648715
[TBL] [Abstract][Full Text] [Related]
17. Binding to mu and delta opioid sites but not kappa sites is inhibited by Fab fragments from a monoclonal antibody directed against the opioid receptor.
Bidlack JM
NIDA Res Monogr; 1986; 75():21-4. PubMed ID: 2828974
[TBL] [Abstract][Full Text] [Related]
18. Role of mu and delta receptors in the supraspinal and spinal analgesic effects of [D-Pen2, D-Pen5]enkephalin in the mouse.
Porreca F; Heyman JS; Mosberg HI; Omnaas JR; Vaught JL
J Pharmacol Exp Ther; 1987 May; 241(2):393-400. PubMed ID: 3033214
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological profiles of fentanyl analogs at mu, delta and kappa opiate receptors.
Maguire P; Tsai N; Kamal J; Cometta-Morini C; Upton C; Loew G
Eur J Pharmacol; 1992 Mar; 213(2):219-25. PubMed ID: 1355735
[TBL] [Abstract][Full Text] [Related]
20. Studies on the effects of glucose in vitro and of the glycaemic state in vivo on the binding characteristics of mu, delta and kappa opiate receptors in mouse brain.
Khawaja XZ; Green IC
Life Sci; 1992; 50(17):1273-81. PubMed ID: 1314928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
